COPD Readmissions: Addressing COPD in the Era of Value-based Health Care

Chest

Volumn 150, Issue 4, 2016, Pages 916-926

  Shah, Tina ^a   Press, Valerie G ^a   Huisingh Scheetz, Megan ^a   White, Steven R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

acute exacerbation of COPD; COPD; emphysema; Medicare Hospital Readmissions Reduction Program (HRRP); readmissions

Indexed keywords

AZITHROMYCIN; ROFLUMILAST; SIMVASTATIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS; DISEASE EXACERBATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; MEDICARE; MORBIDITY; PATIENT EDUCATION; PREDICTION; PRIORITY JOURNAL; PULMONARY REHABILITATION; REVIEW; RISK FACTOR; UNITED STATES; GOVERNMENT; HOSPITALIZATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REIMBURSEMENT; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); HEALTH POLICY; HOSPITALIZATION; HUMANS; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; REIMBURSEMENT MECHANISMS; RISK ASSESSMENT; UNITED STATES;

EID: 84994509597     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.05.002     Document Type: Review

References (88)

1. 1 Halbert, R.J., Natoli, J.L., Gano, A., Badamgarav, E., Buist, A.S., Mannino, D.M., Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28:3 (2006), 523–532.
2. 2 Morbidity and Mortality: 2012 Chartbook on Cardiovascular, Lung and Blood Diseases, 2012, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD, 5–9.
3. 3 National Center for Health Statistics. Leading causes of death. Centers for Disease Control and Prevention Website. http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm. Accessed February 20, 2016.
4. 4 Jencks, S.F., Williams, M.V., Coleman, E.A., Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360:14 (2009), 1418–1428.
5. 5 Shah, T., Churpek, M.M., Coca Perraillon, M., Konetzka, R.T., Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion. Chest 147:5 (2015), 1219–1226.
6. 6 Quality AfHRa. Guide to Prevention Quality Indicators: Hospital Admission for Ambulatory Care Sensitive Conditions. In: Services DoHaH, ed. Rockville, MD: AHRQ; 2002:1.
7. 7 Kristensen, S.R., Bech, M., Quentin, W., A roadmap for comparing readmission policies with application to Denmark, England, Germany and the United States. Health Policy 119:3 (2015), 264–273.
8. 8 Laverty, A.A., Elkin, S.L., Watt, H.C., et al. Impact of a COPD discharge care bundle on readmissions following admission with acute exacerbation: interrupted time series analysis. PLoS One, 10(2), 2015, e0116187.
9. 9 Shu, C.C., Lin, Y.F., Hsu, N.C., Ko, W.J., Risk factors for 30-day readmission in general medical patients admitted from the emergency department: a single centre study. Intern Med J 42:6 (2012), 677–682.
10. 10 Drye, E., Lindenaurer, P.K., Wang, C., et al. 2013 Measure Updates and Specifications Report: Hospital-Level 30-day Readmission Following Admission for an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Version 2.0). 2013, Yale-New Haven Health Services Corporation/Center of Outcomes Research and Evaluation, New Haven, CT.
11. 11 Grosso, L., Lundenaur, P.K., Wang, C., Hospital-Level 30-Day Readmission Following Admission for an Acute Exacerbation of Chronic Obstructive Pulmonary Disease. 2011, Yale-New Haven Health Services Corporation/Center for Outcomes Research and Evaluation, New Haven, CT.
12. 12 Benbassat, J., Taragin, M., Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med 160:8 (2000), 1074–1081.
13. 13 Rosen, A.K., Chen, Q., Shin, M.H., et al. Medical and surgical readmissions in the Veterans Health Administration: what proportion are related to the index hospitalization?. Med Care 52:3 (2014), 243–249.
14. 14 Auerbach, A.D., Kripalani, S., Vasilevskis, E.E., et al. Preventability and causes of readmissions in a national cohort of general medicine patients. JAMA Intern Med 176:4 (2016), 484–493.
15. 15 CMS.gov. Readmissions reduction program. Centers for Medicare & Medicaid Services Website. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html. Accessed December 15, 2015.
16. 16 Feemster, L.C., Au, D.H., Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med 189:6 (2014), 634–639.
17. 17 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2016, Global Initiative for Chronic Obstructive Lung Disease (GOLD) http://goldcopd.org/. Accessed August 9, 2016.
18. 18 Joynt, K.E., Jha, A.K., Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA 309:4 (2013), 342–343.
19. 19 Joynt, K.E., Jha, A.K., A path forward on Medicare readmissions. N Engl J Med 368:13 (2013), 1175–1177.
20. 20 Krumholz, H.M., Lin, Z., Keenan, P.S., et al. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA 309:6 (2013), 587–593.
21. 21 Seemungal, T.A., Donaldson, G.C., Bhowmik, A., Jeffries, D.J., Wedzicha, J.A., Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:5 (2000), 1608–1613.
22. 22 National Institute for Health and Care Excellence. Chronic Obstructive Pulmonary disease in Over 16s: Diagnosis and Management. London, England: June 23, 2010.
23. 23 Vestbo, J., Hurd, S.S., Agusti, A.G., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:4 (2013), 347–365.
24. 24 Criner, G.J., Bourbeau, J., Diekemper, R.L., et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147:4 (2015), 894–942.
25. 25 Celli, B.R., Decramer, M., Wedzicha, J.A., et al. An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 191:7 (2015), e4–e27.
26. 26 Naylor, M.D., Brooten, D.A., Campbell, R.L., Maislin, G., McCauley, K.M., Schwartz, J.S., Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial. J Am Geriatrics Soc 52:5 (2004), 675–684.
27. 27 Stauffer, B.D., Fullerton, C., Fleming, N., et al. Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controls. Arch Intern Med 171:14 (2011), 1238–1243.
28. 28 Prieto-Centurion, V., Rolle, A.J., Au, D.H., et al. Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 190:9 (2014), 989–995.
29. 29 Stein, B.D., Charbeneau, J.T., Lee, T.A., et al. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD 7:3 (2010), 164–171.
30. 30 Cooke, C.R., Joo, M.J., Anderson, S.M., et al. The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res, 11, 2011, 37.
31. 31 Leuppi, J.D., Schuetz, P., Bingisser, R., et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 309:21 (2013), 2223–2231.
32. 32 Press, V.G., Arora, V.M., Shah, L.M., et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med 26:6 (2011), 635–642.
33. 33 Stein, B.D., Bautista, A., Schumock, G.T., et al. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest 141:1 (2012), 87–93.
34. 34 National Center for Health Statistics. International Classification of Diseases (ICD-10-CM/PCS) transition, background. Centers for Disease Control and Prevention Website. http://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm. Accessed March 1, 2016.
35. 35 Anecchino, C., Rossi, E., Fanizza, C., De Rosa, M., Tognoni, G., Romero, M., Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chronic Obstruct Pulmon Dis 2:4 (2007), 567–574.
36. 36 Holguin, F., Folch, E., Redd, S.C., Mannino, D.M., Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128:4 (2005), 2005–2011.
37. 37 Barnes, P.J., Celli, B.R., Systemic manifestations and comorbidities of COPD. Eur Respir J 33:5 (2009), 1165–1185.
38. 38 Padeletti, M., Jelic, S., LeJemtel, T.H., Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Int J Cardiol 125:2 (2008), 209–215.
39. 39 Fried, L.P., Tangen, C.M., Walston, J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:3 (2001), M146–M156.
40. 40 Gobbens, R.J., Luijkx, K.G., Wijnen-Sponselee, M.T., Schols, J.M., Towards an integral conceptual model of frailty. J Nutrition Health Aging 14:3 (2010), 175–181.
41. 41 McNallan, S.M., Singh, M., Chamberlain, A.M., et al. Frailty and healthcare utilization among patients with heart failure in the community. JACC Heart Fail 1:2 (2013), 135–141.
42. 42 Guralnik, J.M., Simonsick, E.M., Ferrucci, L., et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:2 (1994), M85–M94.
43. 43 Park, S.K., Richardson, C.R., Holleman, R.G., Larson, J.L., Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003-2006). Heart Lung 42:3 (2013), 163–170.
44. 44 Singh, G., Zhang, W., Kuo, Y.F., Sharma, G., Association of psychological disorders with 30-day readmission rates in patients with COPD. Chest 149:4 (2016), 905–915.
45. 45 Iyer, A.S., Bhatt, S.P., Garner, J.J., et al. Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 13:2 (2016), 197–203.
46. 46 Harpole, L.H., Williams, J.W. Jr., Olsen, M.K., et al. Improving depression outcomes in older adults with comorbid medical illness. Gen Hosp Psychiatry 27:1 (2005), 4–12.
47. 47 Hartl, S., Lopez-Campos, J.L., Pozo-Rodriguez, F., et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD audit. Eur Respir J 47:1 (2016), 113–121.
48. 48 Greening, N.J., Harvey-Dunstan, T.C., Chaplin, E.J., et al. Bedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory disease. Am J Respir Crit Care Med 192:7 (2015), 810–816.
49. 49 Bahadori, K., FitzGerald, J.M., Risk factors of hospitalization and readmission of patients with COPD exacerbation—systematic review. Int J Chron Obstruct Pulmon Dis 2:3 (2007), 241–251.
50. 50 Celli, B.R., Cote, C.G., Marin, J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:10 (2004), 1005–1012.
51. 51 Lightowler, J.V., Wedzicha, J.A., Elliott, M.W., Ram, F.S., Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ, 326(7382), 2003, 185.
52. 52 Shah, F., Burack, O., Boockvar, K.S., Perceived barriers to communication between hospital and nursing home at time of patient transfer. J Am Med Dir Assoc 11:4 (2010), 239–245.
53. 53 LaMantia, M.A., Scheunemann, L.P., Viera, A.J., Busby-Whitehead, J., Hanson, L.C., Interventions to improve transitional care between nursing homes and hospitals: a systematic review. J Am Geriatr Soc 58:4 (2010), 777–782.
54. 54 Kon, S.S., Jones, S.E., Schofield, S.J., et al. Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study. Thorax 70:12 (2015), 1131–1137.
55. 55 Morley, J.E., Vellas, B., van Kan, G.A., et al. Frailty consensus: a call to action. J Am Med Dir Assoc 14:6 (2013), 392–397.
56. 56 Suh, E.S., Mandal, S., Harding, R., et al. Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD. Thorax 70:12 (2015), 1123–1130.
57. 57 Sharif, R., Parekh, T.M., Pierson, K.S., Kuo, Y.F., Sharma, G., Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc 11:5 (2014), 685–694.
58. 58 Shams, I., Ajorlou, S., Yang, K., A predictive analytics approach to reducing 30-day avoidable readmissions among patients with heart failure, acute myocardial infarction, pneumonia, or COPD. Health Care Manag Sci 18:1 (2015), 19–34.
59. 59 Almagro, P., Soriano, J.B., Cabrera, F.J., et al. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest 145:5 (2014), 972–980.
60. 60 Zwerink, M., Brusse-Keizer, M., van der Valk, P.D., et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, 2014, CD002990.
61. 61 Press, V.G., Arora, V.M., Shah, L.M., et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med 27:10 (2012), 1317–1325.
62. 62 Press, V.G., Arora, V.M., Trela, K.C., et al. Effectiveness of interventions to teach metered-dose and Diskus inhaler techniques: a randomized trial. Ann Am Thorac Soc 13:6 (2016), 816–824.
63. 63 Sharma, G., Kuo, Y.F., Freeman, J.L., Zhang, D.D., Goodwin, J.S., Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med 170:18 (2010), 1664–1670.
64. 64 Lykkegaard, J., Larsen, P.V., Paulsen, M.S., Sondergaard, J., General practitioners' home visit tendency and readmission-free survival after COPD hospitalisation: a Danish nationwide cohort study. NPJ Prim Care Respir Med, 24, 2014, 14100.
65. 65 Puhan, M.A., Gimeno-Santos, E., Scharplatz, M., Troosters, T., Walters, E.H., Steurer, J., Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev(10), 2011, Cd005305.
66. 66 Revitt, O., Sewell, L., Morgan, M.D., Steiner, M., Singh, S., Short outpatient pulmonary rehabilitation programme reduces readmission following a hospitalization for an exacerbation of chronic obstructive pulmonary disease. Respirology 18:7 (2013), 1063–1068.
67. 67 Greening, N.J., Williams, J.E., Hussain, S.F., et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ, 349, 2014, g4315.
68. 68 McLean, S., Nurmatov, U., Liu, J.L., Pagliari, C., Car, J., Sheikh, A., Telehealthcare for chronic obstructive pulmonary disease: Cochrane Review and meta-analysis. Br J Gen Pract 62:604 (2012), e739–e749.
69. 69 Blee, J., Roux, R.K., Gautreaux, S., Sherer, J.T., Garey, K.W., Dispensing inhalers to patients with chronic obstructive pulmonary disease on hospital discharge: effects on prescription filling and readmission. Am J Health Syst Pharm 72:14 (2015), 1204–1208.
70. 70 Eisenhower, C., Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD. Ann Pharmacother 48:2 (2014), 203–208.
71. 71 Fu, A.Z., Sun, S.X., Huang, X., Amin, A.N., Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 10 (2015), 909–915.
72. 72 Uzun, S., Djamin, R.S., Kluytmans, J.A., et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2:5 (2014), 361–368.
73. 73 Criner, G.J., Connett, J.E., Aaron, S.D., et al. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med 370:23 (2014), 2201–2210.
74. 74 Jeppesen, E., Brurberg, K.G., Vist, G.E., et al. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 5, 2012, CD003573.
75. 75 Kruis, A.L., Smidt, N., Assendelft, W.J., et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, 2013, CD009437.
76. 76 Bourbeau, J., Julien, M., Maltais, F., et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 163:5 (2003), 585–591.
77. 77 Rice, K.L., Dewan, N., Bloomfield, H.E., et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 182:7 (2010), 890–896.
78. 78 Fan, V.S., Gaziano, J.M., Lew, R., et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 156:10 (2012), 673–683.
79. 79 Hansen, L.O., Greenwald, J.L., Budnitz, T., et al. Project BOOST: effectiveness of a multihospital effort to reduce rehospitalization. J Hosp Med 8:8 (2013), 421–427.
80. 80 Voss, R., Gardner, R., Baier, R., Butterfield, K., Lehrman, S., Gravenstein, S., The care transitions intervention: translating from efficacy to effectiveness. Arch Intern Med 171:14 (2011), 1232–1237.
81. 81 Linden, A., Butterworth, S., A comprehensive hospital-based intervention to reduce readmissions for chronically ill patients: a randomized controlled trial. Am J Manag Care 20:10 (2014), 783–792.
82. 82 Adamson, S.L., Burns, J., Camp, P.G., Sin, D.D., van Eeden, S.F., Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 11 (2016), 61–71.
83. 83 Axon, R.N., Cole, L., Moonan, A., et al. Evolution and initial experience of a statewide care transitions quality improvement collaborative: preventing avoidable readmissions together. Popul Health Manag 19:1 (2016), 4–10.
84. 84 “Health Policy Brief: The Two-Midnight Rule,” Health Affairs, January 22, 2015. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=133. Accessed March 19, 2016.
85. 85 Gilman, M., Adams, E.K., Hockenberry, J.M., Wilson, I.B., Milstein, A.S., Becker, E.R., California safety-net hospitals likely to be penalized by ACA value, readmission, and meaningful-use programs. Health Aff (Millwood) 33:8 (2014), 1314–1322.
86. 86 Berenson, J., Shih, A., Higher readmissions at safety-net hospitals and potential policy solutions. Issue Brief 34 (2012), 1–16.
87. 87 CMS.gov. FY 2016 IPPS final rule home page. Centers for Medicare & Medicaid Services Website. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/FY2016-IPPS-Final-Rule-Home-Page.html. Accessed March 1, 2016.
88. 88 CMS.gov. Bundled Paments for Care Improvement (BPCI) Initiative: General Information. Centers for Medicare & Medicaid Services Website. https://innovation.cms.gov/initiatives/bundled-payments/. Accessed March 19, 2016.